
Commentary|Podcasts|July 14, 2023
Pharmacy Focus: Psychedelic Pharmacy - Digital Therapeutics in Psychedelic Medicine
David Keene, vice president of Digital Therapeutics at atai Life Sciences, discussed the growth and future of digital therapeutics.
Advertisement
This month, we sat down with David Keene, vice president of Digital Therapeutics at atai Life Sciences, to discuss the growth and future of digital therapeutics.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Trump Executive Order Recommends Separating MMR Into 3 Shots
2
GLP-1s: A New Frontier in Substance Use Disorder Management
3
Tirzepatide Cuts MACE Risk in Diabetes With Heart Disease
4
Expert Q&A: Why COVID-19 Post-Exposure Prophylaxis Is a Pharmacist's New Tool
5




































































































